SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme Technologies trades in green on the BSE

21 Sep 2022 Evaluate

Advanced Enzyme Technologies is currently trading at Rs. 293.85, up by 0.80 points or 0.27% from its previous closing of Rs. 293.05 on the BSE.

The scrip opened at Rs. 292.70 and has touched a high and low of Rs. 297.55 and Rs. 288.20 respectively. So far 69090 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 421.00 on 11-Oct-2021 and a 52 week low of Rs. 257.00 on 25-Feb-2022.

Last one week high and low of the scrip stood at Rs. 308.50 and Rs. 263.05 respectively. The current market cap of the company is Rs. 3278.50 crore.

The promoters holding in the company stood at 52.70%, while Institutions and Non-Institutions held 24.98% and 22.32% respectively.

Advanced Enzyme Technologies’ subsidiary -- Advanced Vital Enzymes has sold 25,73,500 shares, amounting to 2.3 per cent stake in Krishna Institute of Medical Sciences (KIMS). The shares were disposed of at an average price of Rs 270 per piece, aggregating to Rs 69.48 crore.

Advanced Enzyme Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.

Advanced Enzyme Share Price

298.60 -0.40 (-0.13%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×